In conclusion, our study indicates that marijuana misuse in combination with specific CNR1 genotypes may contribute to WM volume deficits and cognitive impairment for a subgroup of schizophrenia patients. These findings suggest that for a proportion of patients within the heterogeneous grouping of schizophrenia, heavy marijuana misuse may be a necessary and/or a sufficient factor in mediating phenotypic features of the disorder.
